CODEINE: Pharmacists Council starts recall of cough syrup

FG Releases Final Admission Status of Pupils of 2019 National Common Entrance Examination - Click Here for Details

TRCN PQE MAY Diet 2019 Passed List (See Full List) - Click Here!

The Pharmacists Council of Nigeria has started recalling cough syrups containing codeine from its stakeholders in compliance with Federal Government directive. The Registrar of PCN, Elijah Mohammed, revealed this in an interview with the News Agency of Nigeria (NAN) on Saturday in Abuja.

NAN recalls that the Minister of Health, Prof. Isaac Adewole, had directed PCN, NAFDAC and other regulatory bodies to supervise the recall of codeine from the market.

Mohammed reaffirmed that codeine is an opioid drug similar to morphine which has been approved and accessed over the counter in low doses for relieving patients of symptoms associated with a dry cough.

Read Also  BabaSuwe Undergoing Treatment In US Hosiptal (Photos)

According to the registrar, codeine in such preparation, usually in smaller doses, serves as a cough suppressant and relieves pain associated with the stress of coughing.

“However, due to its inherent properties when used in high doses over a long period, it has been associated with dependence and powerful addictive propensity especially when used for recreational purpose,’’ the registrar said.

Click Here to Join Newsnow Nigeria WhatsApp Group for Breaking News Alerts
Read Also  World Celebrates #NoBraDay In Support of #BreastCancerAwarenessMonth (Read Comments)

Mohammed noted that the council in view of the ministerial directive has carried out enforcement exercise in Ogun, Sokoto and Nasarawa States, adding that same activity is currently going on in Adamawa.

Follow Us on FACEBOOK, TWITTER

Do You Know Nigeria? Attempt 10 simple questions on Nigeria for FREE and Win FREE N500 Airtime - Click Here to Participate!

Click Here to Join Newsnow Nigeria WhatsApp Group for Breaking News Alerts

For your news articles, press release, Breaking News, send e-mail to [email protected]